Intravoxel Incoherent Motion Prognostic Value in the Initial Evaluation of Patients With Acute Ischemic Strokes Using 3 Tesla Magnetic Resonance Imaging
IMPROVES
1 other identifier
observational
274
1 country
1
Brief Summary
Ischemic strokes are the first cause of handicap in adult people, the second cause of dementia and the third cause of death in France. Brain Magnetic Resonance (MR) initial assessment is mandatory to get the right diagnosis, to exclude hemorrhagic lesions and to determine the best treatment. The conventional diffusion weighted imaging sequence is used to establish the diagnosis and to estimate the volume of ischemic lesions. The perfusion weighted imaging sequences are also used to assess the diffusion-perfusion mismatch which is supposed to be the ischemic penumbra corresponding to territories that could be saved with appropriate treatments. IntraVoxel Incoherent Motion (IVIM) is a multi-b diffusion sequence which allows to extract four quantitative variables (D, D\*, f, ADC) related to the true molecular diffusion and correlated to the microvascular perfusion. It's a quick sequence with no need of contrast injection and allowing a perfect coregistration with the true diffusion. It has been validated in many pathologies but not in acute strokes. The feasibility of this sequence in acute ischemic strokes has already been assessed with interesting results. The study aims to assess the correlation between the quantitative values of IVIM at initial MR exam and the modified Rankin Scale (mRS) score 3 months after an acute ischemic stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 10, 2017
CompletedFirst Submitted
Initial submission to the registry
August 28, 2017
CompletedFirst Posted
Study publicly available on registry
August 29, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 14, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 14, 2021
CompletedMarch 25, 2026
March 1, 2026
3.6 years
August 28, 2017
March 23, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Correlation between quantitative values of IntraVoxel Incoherent Motion at initial Magnetic Resonance Imaging (MRI) and the modified Rankin Scale (mRS) at 3 months after an acute ischemic stroke.
IntraVoxel Incoherent Motion is a diffusion sequence which allows to extract four quantitative variables (D, D\*, f, ADC) related to the true molecular diffusion and correlated to the microvascular perfusion. We aim to assess the correlation between the quantitative values of IVIM at initial exam and the mRS score 3 months after an acute ischemic stroke.
3 months
Interventions
The IVIM diffusion sequence with a duration of 2 minutes is added to the imaging protocol.
Eligibility Criteria
Patients with an acute ischemic stroke
You may qualify if:
- Adult patients
- Admitted for an acute ischemic stroke
- Affiliated to a Social Security scheme
You may not qualify if:
- Absolute contraindications to MRI
- Pregnant or breastfeeding woman
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondation Ophtalmologique A. de Rothschild
Paris, France
Related Publications (1)
Sajust de Bergues de Escalup A, Duron L, Seners P, Sabben C, Obadia M, Yavchitz A, Savatovsky J, Lecler A. Prediction of functional outcome in patients with ischemic stroke using advanced diffusion-weighted MRI parameters at 3 Tesla. Diagn Interv Imaging. 2026 Mar 19:S2211-5684(26)00049-5. doi: 10.1016/j.diii.2026.03.001. Online ahead of print.
PMID: 41862395RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Augustin Lecler, MD
Fondation Ophtalmologique A. de Rothschild
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 28, 2017
First Posted
August 29, 2017
Study Start
August 10, 2017
Primary Completion
March 14, 2021
Study Completion
June 14, 2021
Last Updated
March 25, 2026
Record last verified: 2026-03